Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus substantially reduced RSV lower respiratory tract.
Study demonstrated a 90% effectiveness of nirsevimab in preventing RSV-associated hospitalizations in infants, with a significant finding being the timely vaccination's role in offering protection.
New data from the Canadian Climate Institute shows that emissions from the oil and gas industry and buildings continued to climb in the previous year, undercutting Canada s overall emissions reduction progress.
New data from the Canadian Climate Institute shows that emissions from the oil and gas industry and buildings continued to climb in the previous year, undercutting Canada s overall emissions reduction progress.
Emissions from oil and gas production and from buildings accounted for 72 per cent of the total increase in emissions, according to a climate change report.